Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin injection vs sclerotherapy in idiopathic achalasia
IRCT201108157335N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Nov 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of botulinum toxin type A in idiopathic achalasia (IA) (2 arms), sponsored by Tehran University of Medical Sciences. Started Nov 2009; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
idiopathic achalasia (IA)
Beyond the preview
Go deeper on IRCT201108157335N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201108157335N1.